Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Mark Jesus M, Magbanua"'
Autor:
Daniel G. Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L. Mayer, Mark Jesus M. Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, W. Fraser Symmans, Charles Perou, Lisa A. Carey, Ann H. Partridge, Hope S. Rugo
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract Association of stromal tumor-infiltrating lymphocytes (sTILs) with survival outcomes among patients with metastatic breast cancer (MBC) remains unclear. The primary objective was to evaluate the association of sTILs with progression-free sur
Externí odkaz:
https://doaj.org/article/83a9a621c06f4389a3a50e11d37a5714
Autor:
Silver Alkhafaji, Denise M. Wolf, Mark Jesus M. Magbanua, Laura J. van ‘t Veer, John W. Park, Laura Esserman, Rita A. Mukhtar
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract This is a secondary data analysis of the TIPPING study, which included 1,121 patients with stage I-III breast cancer who had enumeration of CTCs (by either CellSearch or immunomagnetic enrichment and flow cytometry [IE/FC]) and disseminated
Externí odkaz:
https://doaj.org/article/6aee9c4d7c8f47af9df92861a7cd3949
Autor:
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura J. van ’t Veer, Mark Jesus M. Magbanua
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-21 (2023)
Abstract Background Despite advances in early detection and therapies, cancer is still one of the most common causes of death worldwide. Since each tumor is unique, there is a need to implement personalized care and develop robust tools for monitorin
Externí odkaz:
https://doaj.org/article/5f15669e1e44477eb4ccfa9566f2c012
Autor:
Mark Jesus M. Magbanua, Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown Swigart, David C. Newitt, Jessica Gibbs, Amy L. Delson, Ekaterina Kalashnikova, Alexey Aleshin, Bernhard Zimmermann, A. Jo Chien, Debu Tripathy, Laura Esserman, Nola Hylton, Laura van ‘t Veer
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract We investigated whether serial measurements of circulating tumor DNA (ctDNA) and functional tumor volume (FTV) by magnetic resonance imaging (MRI) can be combined to improve prediction of pathologic complete response (pCR) and estimation of
Externí odkaz:
https://doaj.org/article/fc14e93945954cfb88f54bbbdcc007fe
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Liquid biopsy biomarkers, such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), are noninvasive diagnostics that could complement predictive and prognostic tools currently used in the clinic. Recent trials of immunotherapy have sh
Externí odkaz:
https://doaj.org/article/e747fad8174441c8b07c1934557ed636
Autor:
Mark Jesus M. Magbanua, Laura van ‘t Veer, Amy S. Clark, A. Jo Chien, Judy C. Boughey, Hyo S. Han, Anne Wallace, Heather Beckwith, Minetta C. Liu, Christina Yau, E. Paul Wileyto, Andrea Ordonez, Tulasi I. Solanki, Feng Hsiao, Jen Chieh Lee, Amrita Basu, Lamorna Brown Swigart, Jane Perlmutter, Amy L. Delson, Lauren Bayne, Shannon Deluca, Stephanie S. Yee, Erica L. Carpenter, Laura J. Esserman, John W. Park, Lewis A. Chodosh, Angela DeMichele
Publikováno v:
Breast Cancer Research and Treatment. 198:383-390
Autor:
Mark Jesus M. Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Wen Li, Amy L. Delson, Smita Asare, Minetta C. Liu, Kathy Albain, A. Jo Chien, Andres Forero-Torres, Claudine Isaacs, Rita Nanda, Debu Tripathy, Angel Rodriguez, Himanshu Sethi, Alexey Aleshin, Matthew Rabinowitz, Jane Perlmutter, W. Fraser Symmans, Douglas Yee, Nola M. Hylton, Laura J. Esserman, Angela M. DeMichele, Hope S. Rugo, Laura J. van ’t Veer
Publikováno v:
Cancer Cell.
Autor:
Hope S. Rugo, John W. Park, Francisco J. Esteva, Minetta C. Liu, P. Kelly Marcom, Erica L. Mayer, Mothaffar F. Rimawi, Janet H. Scott, Jimmy Hwang, Amy DeLuca, Lisa A. Carey, Mark Jesus M. Magbanua
Purpose: Recent developments in rare-cell technology have led to improved blood-based assays that allow for the reliable detection, enumeration, and more recently, genomic profiling of circulating tumor cells (CTC). We evaluated two different approac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bf49a776e9031049580fdd6286a8dfe
https://doi.org/10.1158/1078-0432.c.6524924
https://doi.org/10.1158/1078-0432.c.6524924
Autor:
Brock A. Peters, Radoje Drmanac, John W. Park, Hope S. Rugo, Snezana Drmanac, Emily Park, Rick Tearle, Katharine Lee, Rebecca Yu Zhang, Yuxiang Li, Xingpeng Chen, Yanxiang Chen, Zhenyu Li, Serban Ciotlos, Qing Mao, Daniel M. Hayden, Jia Liu, Xuhao Luo, Misha R. Agarwal, Robert Chin, Mark Jesus M. Magbanua, Natali Gulbahce
Distribution of allele fraction of inherited and somatic variants before and after filtering. This figure is similar to Fig. 4a, but includes a plotting of all somatic variants before filtering (black), which contains a large number of false positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d5568c9096d7e07789f964b7c311c05
https://doi.org/10.1158/0008-5472.22414221.v1
https://doi.org/10.1158/0008-5472.22414221.v1
Autor:
John W. Park, Laura van't Veer, Maura Dickler, Steven J. Isakoff, William T. Barry, Terry Hyslop, Brandelyn Pitcher, Jin Sun Lee, Janet H. Scott, Eduardo V. Sosa, Praveen Pendyala, Ritu Roy, Louai Hauranieh, Denise M. Wolf, Hope S. Rugo, Mark Jesus M. Magbanua
Supplementary Figure 1. Development, optimization and performance of the gene expression assay. Supplementary Figure 2. Evaluation of assay performance using cancer cell line spike-in models. Supplementary Figure 3. Sample processing and quality cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16806d8d2c1c645aae98ad79edc4ff91
https://doi.org/10.1158/1078-0432.22461276
https://doi.org/10.1158/1078-0432.22461276